Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Clinical safety and efficacy of TS-110 for inflammation and pain

June 12, 1997

Long-term Enbrel safe and effective in RA

June 11, 1997

Development of anti-cytokine antibody product for RA progresses

June 9, 1997

Astra discloses iNOS inhibitors

June 9, 1997

COX-2 inhibitors from Merck Frosst

June 9, 1997

Encouraging phase II data with Connetics' ConXn reported

June 6, 1997

Organon team identifies rheumatoid arthritis-related antigen

June 5, 1997

New NSAID under development in Russia

June 2, 1997

Hoechst discloses agents for immune/autoimmune and other disorders

May 30, 1997

Daiichi reports compounds for RA, allergy and transplant rejection

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...